You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Investigational Drug Information for Tegafur


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Tegafur?

Tegafur is an investigational drug.

There have been 152 clinical trials for Tegafur. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2014.

The most common disease conditions in clinical trials are Stomach Neoplasms, Colorectal Neoplasms, and Pancreatic Neoplasms. The leading clinical trial sponsors are Fudan University, Taiho Pharmaceutical Co., Ltd., and National Cancer Institute (NCI).

There are eight hundred and twenty-eight US patents protecting this investigational drug and sixteen international patents.

Recent Clinical Trials for Tegafur
TitleSponsorPhase
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsChugai Pharmaceutical Co.Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1
An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGCXijing HospitalN/A

See all Tegafur clinical trials

Clinical Trial Summary for Tegafur

Top disease conditions for Tegafur
Top clinical trial sponsors for Tegafur

See all Tegafur clinical trials

US Patents for Tegafur

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tegafur ⤷  Try a Trial Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA) ⤷  Try a Trial
Tegafur ⤷  Try a Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP) ⤷  Try a Trial
Tegafur ⤷  Try a Trial Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same Protalix Ltd. (Carmiel, IL) ⤷  Try a Trial
Tegafur ⤷  Try a Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA) ⤷  Try a Trial
Tegafur ⤷  Try a Trial Method of diagnosing and treating cancer using B-catenin splice variants The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tegafur

Drugname Country Document Number Estimated Expiration Related US Patent
Tegafur Australia AU2014232383 2033-03-15 ⤷  Try a Trial
Tegafur Australia AU2019202731 2033-03-15 ⤷  Try a Trial
Tegafur Australia AU2019288275 2033-03-15 ⤷  Try a Trial
Tegafur Brazil BR112015023267 2033-03-15 ⤷  Try a Trial
Tegafur Brazil BR112020025927 2033-03-15 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.